Is There a Role for Immunotherapy in Prostate Cancer?Alessandro Rizzo, Francesco Massari, Liang Cheng et al.|Cells|2020Cited by 85
Discontinuation rate and serious adverse events of chemoimmunotherapy as neoadjuvant treatment for triple-negative breast cancer: a systematic review and meta-analysisAlessandro Rizzo, Mario Giuliano, Francesca Matilde Schipilliti et al.|ESMO Open|2023Cited by 31
266P Discontinuation rate and serious adverse events of chemoimmunotherapy as neoadjuvant treatment for triple-negative breast cancer: A systematic review and meta-analysisFrancesca Matilde Schipilliti, Mario Giuliano, Michelino De Laurentiis et al.|Annals of Oncology|2023Cited by 0